We demonstrate that SET silencing has a detrimental effect on the proliferation of KMT2A-wt- leukemic cells, as also observed in CML and solid tumors [21, 57–59]. This evidence concerns the gene SET and chronic myelogenous leukemia, BCR-ABL1 positive.